cancer

Biotech By Adam Feuerstein

FDA halts Allogene blood cancer trials after patient found to have ‘chromosomal abnormality’

First Opinion By Hil Moss

Enough pink: We’re doing Breast Cancer Awareness Month all wrong

In the Lab By Andrew Joseph

Genetic information can be messy. Mapping proteins could offer a clearer view of what’s driving cancer

First Opinion By Richard Maziarz and Sophie Snyder

Proposals to cap Medicare Part B payments will limit outpatient access to CAR-T

Pharmalot By Ed Silverman

Pharmalittle: J&J says its Covid-19 shot is more effective in two doses; India plans to resume Covid-19 vaccine exports

Pharmalot By Casey Ross

Pharmalittle: FDA scientists skeptical on boosters; moderate Democrats sink Pelosi’s drug pricing proposal

Pharmalot By Ed Silverman

Cancer drug indications remain on labels even after trials fail to confirm their benefits

Health By Elizabeth Cooney

Pandemic lockdown tied to worse outcomes in metastatic colorectal cancer, French study says

In the Lab By Theresa Gaffney

Never-smokers’ lung cancers are genetically different from smokers’ tumors, study shows

First Opinion By Annette L. Stanton and Tammie Denyse

‘Reentry’ after cancer treatment offers lessons for emerging from the pandemic

First Opinion By H. Gilbert Welch

Liquid biopsy: misplaced faith in early cancer detection?

Health By Elizabeth Cooney

Does breast density matter for older women’s risk of cancer?

Biotech By Damian Garde

Sesen Bio pulls E.U. application for FDA-rejected cancer drug

Biotech By Matthew Herper

Illumina purchases Grail without clearance from FTC or European Union

Exclusive By Damian Garde

Sesen Bio trial of cancer drug marked by misconduct and worrisome side effects, documents show

In the Lab By Claudia López Lloreda

New immunotherapy approach wiped out tumors in two patients with advanced lung cancer, study reports

Health By Nicholas St. Fleur

STAT+ Conversation: Blueprint for cancer drugs

First Opinion By Philip E. Castle

Applying a pandemic-like response to cancer prevention

First Opinion Podcast By Patrick Skerrett

Listen: A longtime glioblastoma survivor on how to keep surviving

First Opinion By Adam Hayden

‘Here be dragons’: Long-term survivors like me can help map the boundaries of cancer

First Opinion By Andrew C. von Eschenbach

With Aduhelm, history can repeat itself by following cancer’s success

First Opinion By Lawrence Ingrassia

Cancer killed my mother, brother, and sisters. As the longest-living member of my family, I was determined to understand why

Health By Carla K. Johnson — Associated Press

Never too late: Cancer centers push patients to quit smoking

Health By Elizabeth Cooney

When Covid first hit, prostate cancer surgeries fell much more for Black men than white men

Health By Theresa Gaffney

Death rates are declining for many common cancers in the U.S., report finds